We are pleased to announce the appointment of Susan Shore, Ph.D. as the Merle Lawrence Collegiate Professor of Otolaryngology Research, effective Sept. 1, 2021. This professorship was established to honor Dr. Lawrence’s legacy and his significant contributions to the University of Michigan, including his role as founder and original director of the Kresge Hearing Research Institute (KHRI). We are honored to have Dr. Lawrence’s name forever connected to KHRI and the Department and are thrilled to appoint Dr. Shore as the inaugural recipient.
Dr. Shore received her B.S. in speech pathology and audiology and her M.A. in hearing science from the University of Witwatersrand in Johannesburg, South Africa. She completed her Ph.D. in physiology at the Kresge Hearing Research Laboratory of the South, Louisiana State University Medical Center. Her postdoctoral fellowships included the University of Pittsburgh and here at the University of Michigan Medical School.
Dr. Shore is an outstanding neuroscientist with a strong international reputation. Her groundbreaking work has contributed to the mission of the Kresge Hearing Research Institute and will be a fitting way to honor Dr. Lawrence’s legacy. She has made seminal contributions to the understanding of the organization of the central auditory system. These discoveries set the stage for revealing circuit alterations after cochlear damage that contribute to tinnitus and hyperacusis (hypersensitivity to sound), conditions that effect 15% of Americans. These studies, which highlighted the somatosensory system as critical player in the development of tinnitus, have led to a potential revolution in the treatment of tinnitus. A combined animal and first human clinical trial published in the prestigious journal Science Translational Medicine in 2018, led to significant worldwide interest and recognition of Dr. Shore and her team.
Please join us in congratulating Dr. Shore on her appointment as the Merle Lawrence Collegiate Professor of Otolaryngology Research.